Nexalin Technology, INC. (NXL) — 10-Q Filings

10-Q Filings (6)

• Nexalin's Losses Widen Amid Revenue Dip, FDA Q-Sub Accepted — Nov 14, 2025 Risk: high
  Nexalin Technology, Inc. (NXL) reported a net loss of $2,276,311 for the three months ended September 30, 2025, compared to a net loss of $2,448,257 for the sam
• Nexalin's Net Loss Widens 25% Amid Zero Revenue in Q2 — Aug 6, 2025 Risk: high
  Nexalin Technology, Inc. reported no revenue for the six months ended June 30, 2025, consistent with the prior year period. The company incurred a net loss of $
• Nexalin Technology Files Q1 2025 10-Q — May 13, 2025 Risk: low
  Nexalin Technology, Inc. filed its 10-Q for the period ending March 31, 2025. The filing includes financial data for the first quarter of 2025 and comparative p
• Nexalin Technology Files Q3 2024 10-Q — Nov 8, 2024 Risk: medium
  Nexalin Technology, Inc. filed its 10-Q for the period ending September 30, 2024. The filing details the company's financial performance and position, including
• Nexalin Technology Files 10-Q for Q2 2024 — Aug 8, 2024 Risk: medium
  Nexalin Technology, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second qua
• Nexalin Technology, Inc. Files 10-Q for Q1 2024 — May 10, 2024 Risk: low
  Nexalin Technology, Inc. (NXL) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. Nexalin Technology, Inc. filed a 10-Q report for the period ending

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX